Vivanza Biosciences Q4 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
1.89
0.01 (0.53%)
0.01 (0.53%)Volume17.68 K
Updated: Fri 11 Sep, 2026 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Vivanza Biosciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6.61 | 45.04 | -85.33% | 4.57 | 359.12% |
| Depreciation/ Amortization | 0.01 | 0.00 | 214.29% | 0.01 | 292.86% |
| Operating Income | -0.24 | 0.21 | 0.00% | -0.14 | -74.22% |
| Net Income | -0.45 | 0.20 | 0.00% | -0.41 | -54.81% |
| Other Operating Expenses Total | 0.01 | 0.09 | -89.41% | 0.10 | -91.41% |
| Net Income Before Taxes | -0.30 | 0.20 | 0.00% | -0.27 | -69.53% |
| Total Revenue | 6.36 | 45.25 | -85.94% | 4.42 | 1194.59% |
| Selling/ General/ Admin Expenses Total | 0.07 | 0.04 | 66.83% | 0.10 | -56.35% |
| Diluted Normalized EPS | -0.11 | 0.05 | 0.00% | -0.11 | -53.97% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.